![]() SHPHF 9 months ago Paid | Other | $0 Per Share |
![]() SHPHF 10 months ago | Other | $0 Per Share |
![]() SHPHF 7 Jun 2023 Paid | Other | $0.04 Per Share |
![]() SHPHF 6 Jun 2023 | Other | $0.01 Per Share |
![]() SHPHF 4 Oct 2022 Paid | Other | $0.04 Per Share |
29 Aug 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
26 Mar 2025 Date | | - Cons. EPS | - EPS |
30 Aug 2024 Date | | - Cons. EPS | - EPS |
27 Aug 2024 Date | | - Cons. EPS | - EPS |
6 Jun 2024 Date | | - Cons. EPS | - EPS |
![]() SHPHF 9 months ago Paid | Other | $0 Per Share |
![]() SHPHF 10 months ago | Other | $0 Per Share |
![]() SHPHF 7 Jun 2023 Paid | Other | $0.04 Per Share |
![]() SHPHF 6 Jun 2023 | Other | $0.01 Per Share |
![]() SHPHF 4 Oct 2022 Paid | Other | $0.04 Per Share |
29 Aug 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
26 Mar 2025 Date | | - Cons. EPS | - EPS |
30 Aug 2024 Date | | - Cons. EPS | - EPS |
27 Aug 2024 Date | | - Cons. EPS | - EPS |
6 Jun 2024 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Dr. Weicheng Guo Ph.D. CEO | OTC PINK Exchange | BMG8162K1137 ISIN |
Hong Kong Country | 2,667 Employees | 2 Oct 2024 Last Dividend | 5 Jun 2014 Last Split | - IPO Date |
Sihuan Pharmaceutical Holdings Group Ltd., established in 2001 and headquartered in Wan Chai, Hong Kong, operates as a robust player in the pharmaceutical sector within the People's Republic of China. As an investment holding entity, the company’s primary activities encompass the research and development, manufacture, marketing, and sales of a diverse range of pharmaceutical and medical aesthetic products. It boasts a broad product portfolio that includes therapeutic solutions in critical areas such as oncology, metabolism, diabetes, cardiovascular and cerebrovascular diseases, modern Chinese medicine, and industrial hemp treatments. Additionally, Sihuan Pharmaceutical extends its market presence to the investment and sale of medical beauty products, the manufacturing of medical instruments, property investments, the construction of medical projects, and project preparation for pharmaceutical products manufacturing. The company is also engaged in providing a variety of services including information support, general and hospital management, biotechnology, technology promotion, and medical aesthetic research and development, making it a comprehensive provider in the healthcare and pharmaceutical industries in China.
Sihuan Pharmaceutical offers a wide range of oncology drugs designed to treat various types of cancer by inhibiting the growth of cancer cells, thereby providing patients with vital treatment options to manage their conditions.
The company provides medications that target the metabolism and diabetes sector, focusing on improving the lives of people living with metabolic disorders and diabetes through innovative therapeutic solutions.
Sihuan Pharmaceutical develops drugs aimed at treating cardiovascular and cerebrovascular diseases, contributing to the prevention and management of heart conditions and strokes through cutting-edge pharmacological treatment.
Embracing the rich heritage of traditional Chinese medical practices, the company also specializes in the production and marketing of modern Chinese medicine formulations, offering alternatives to conventional medicine and enhancing patient care with holistic approaches.
Exploring the therapeutic potential of industrial hemp, Sihuan Pharmaceutical is at the forefront of developing and supplying products derived from industrial hemp, targeting a variety of medical conditions with natural solutions.
The company's foray into medical aesthetics involves the investment and sale of medical beauty products, leveraging biotechnology to offer innovative cosmetic solutions that meet diverse beauty and skincare needs.
Complementing its pharmaceutical and medical beauty product lines, Sihuan Pharmaceutical also engages in the manufacture of medical instruments, ensuring the availability of high-quality tools and devices for healthcare providers.
Extending its expertise beyond pharmaceuticals, the company invests in properties and undertakes the construction of medical projects, demonstrating its multifaceted approach to supporting healthcare infrastructure.
With services that span information support and hospital management, Sihuan Pharmaceutical offers comprehensive solutions to improve hospital operations and patient care through technology and effective management practices.
The company is devoted to the promotion of biotechnology and the advancement of medical aesthetic research and development, showcasing its commitment to innovation and the future of medical care.